Once again the lead blanket offer weighs on the stock of TISA. Hopefully Izhak will be able to address some of the issues that were not clarified on the conference call. Maybe he can speak to the analysts that participated in the stock offering at higher prices and get them to lay out the exciting story that one day TISA will represent. Maybe tomorrows Roth conference will bring new buyers. Right now with new shareholders from the secondary, a declining stock price, and little info as to what the money was needed for, investors are stepping back and seeing how this story unfolds.
With TISA presenting Tuesday at the Roth Conference and having many 1 on 1's with Institutional clients, hopefully Izhak can give a much clearer message as to where this company is going than what was given on the Conference call. Hopefully a Roth analyst or others that participated in the secondary, will also give some clarity to this story shortly.
Very disappointing action today when one would have thought that a conference call and a presentation at the Roth conference would have brought good news. Maybe soon, certainly didn't happen today
With a conference call today and many 1 on 1 meetings with institutional investors at the Roth conference, TISA will have many opportunities to explain the quarter and highlight possible acquisition strategies, SAAS revenues, and the growth of their MOBI platform going forward. Should be an interesting day and IDDR85 is correct in highlighting that the growth in SAAS revenues is masking the strong overall growth in their business. Institutional investors, which should be many after the secondary, should readily see this.
Seems like orders never move this stock. Waiting anxiously for management to announce an acquisition [must be doing something with this new cash raised] and an elaboration on what is happening on the banking front. Stock just drifting down until we get clarity in those two areas. Maybe the analysts are also waiting for elaboration before picking up coverage. Some good news on these two fronts could send the stock much higher. With an earnings announcement date and a conference coming, hopefully we will hear something shortly.
I have no idea but would guess it is private company., Would also guess that eps are out before the Roth Conference. Hopefully we will have a management that can talk about what is going on prior to these 2 events. Would be nice if we also had a few analysts that could speculate about what is happening
Would sure be nice to hear what managements plans are for the recently raised cash. Contract announcements are nice but how management is going to use the cash raised is far more important in the short, medium and long term. With conferences coming [Roth in March], and hopefully analysts with research reports waiting in the wings [they usually do that after raising capital for a company], it would be nice to know managements game plan. It has been over 3 weeks since the capital raise, would expect something soon. Heck, Facebook took no time to spend $16 billion dollars.
Things we know. TISA didn't need $14 million for working capital - they had plenty to grow the business and proceed as they were. They got 2 new firms, Cannacord and Roth to do the deal which usually means analyst coverage at some point. My guess is now that the capital has been raised they are putting the finishing touches on an acquisition that they have been working on for some time. Since another Wall St. firm is probably handling the acquisition we have the possibility of additional analyst coverage. Stay tune, would guess we will see an accretive acquisition announced shortly with analyst coverage following shortly thereafter.
This underfollowed tech company should have lots of excitement coming. Remember it was over 6 before the deal was announced and I would guess the deal would only be very additive so expect to see higher prices shortly. Here's hoping
Hard to believe they would do a secondary and then report a stinker quarter - that would leave a lot of bag holders and underwriters with angry customers. Would guess that the quarter was as expected or better and that the money is solely for an accretive acquisition. They are generating positive cash flow and had some cash, so raising 14 million can only be for an acquisition. IMHO
OCLS needs to show that they have put Ruthigen behind them, either through an IPO, selling the product for licensing rights to another biotech company, or completely stopping funding. This product has killed the Microcyn story and saddled OCLS with losses that they cannot afford. It has been going on for far too long and the bleeding will continue to keep investors away. Why has OCLS kept this costly product, perhaps Hoji is the only one who knows, but until this is put behind them investors will stay away from the company.
Very surprised at the negative reaction to the financing. It is obvious the proceeds are being used to make an acquisition which should be announced shortly. One would expect the acquisition to be accretive besides adding depth and breadth to their product and management. In addition there will be more street coverage of a very exciting, little known company. Right now we only have the negative effects of the secondary. Once we have the explanation of what the proceeds are for, we will have a more exciting story than ever. Stay tuned, the news should all be good from here on.
One would have to believe that the quarter was a good one since a secondary is not done in front of a bad quarter that is already completed. Secondly, TISA is an unknown story that has a very limited stock float. The underwriters should be able to find a few institutions to pick up the 3 million share secondary that was filed in the S3 and leave many institutions wanting more. The acquisition will hopefully be accretive to earnings and round out the product line. Finally with our 65 million dollar market cap [which is only 2X revenues] we should compare very favorably to MITK which has a 185 million dollar market cap and only 15 million in revenues. Many investors will be awakened to an exciting, little known opportunity. Hence the possibility of the offering pricing higher than its current price.
Should be exciting times. TISA would only need the funds [previously an S3 was filed] to fund an acquisition. Looks like TISA has found one and my guess is that it will buttress any weak areas the company might have and give us the breadth of product and services that will make us a big time company. Wouldn't be surprised if deal is done at higher than current prices since new Investment Banking firms such as Cannacord and Roth will be behind the company. Exciting times
If management would give some update on how they did last quarter and if the new President and a few insiders would purchase some stock. Nothing like an insider buy to instill confidence. This straight down move in the stock as shorts pressure TEAR with impunity, without any management response, is extremely tough on the defending longs. Let's hear something from management, it has been a long time.